103 related articles for article (PubMed ID: 3570047)
1. 1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer.
Piver MS; Lele SB; Patsner B; McPhee ME
Gynecol Oncol; 1987 May; 27(1):24-33. PubMed ID: 3570047
[TBL] [Abstract][Full Text] [Related]
2. cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer.
Piver MS; Lele SB; Malfetano JH
Gynecol Oncol; 1987 Jan; 26(1):71-6. PubMed ID: 3792937
[TBL] [Abstract][Full Text] [Related]
3. Combination cyclophosphamide, adriamycin, and cis-platinum in recurrent and metastatic cervical carcinoma.
De Murua EO; George M; Pejovic MH; Dewailly J; Wolff JP
Gynecol Oncol; 1987 Feb; 26(2):225-7. PubMed ID: 3804038
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, Adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinoma.
Lele SB; Piver MS; Barlow JJ
Gynecol Oncol; 1983 Aug; 16(1):15-8. PubMed ID: 6688405
[TBL] [Abstract][Full Text] [Related]
5. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of disseminated seminoma with combination of cis-diamminedichloroplatinum (II) and cyclophosphamide.
Vugrin D; Whitemore WJ; Batata M
Cancer Clin Trials; 1981; 4(4):423-7. PubMed ID: 7198516
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
9. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix.
Piver MS; Barlow JJ; Lele SB; Maniccia M
Gynecol Oncol; 1984 Jul; 18(3):313-9. PubMed ID: 6540221
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
11. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
Ghaemmaghami F; Behtash N; Yarandi F; Moosavi A; Modares M; Toogeh G; Khanafshar N
J Obstet Gynaecol; 2003 Jul; 23(4):422-5. PubMed ID: 12881087
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
Vogl SE; Seltzer V; Camacho F; Davis TE
J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
[No Abstract] [Full Text] [Related]
14. Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series.
Khoury-Collado F; Bowes RJ; Jhamb N; Aghajanian C; Abu-Rustum NR
Gynecol Oncol; 2007 Jun; 105(3):823-5. PubMed ID: 17363045
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide.
Hoffman MS; Roberts WS; Bryson SC; Kavanagh JJ; Cavanagh D; Lyman GH
Gynecol Oncol; 1988 Jan; 29(1):32-6. PubMed ID: 3338661
[TBL] [Abstract][Full Text] [Related]
16. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent.
Seltzer V; Vogl S; Kaplan B
Gynecol Oncol; 1985 Jun; 21(2):167-76. PubMed ID: 3921437
[TBL] [Abstract][Full Text] [Related]
17. Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.
Takekuma M; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
J Gynecol Oncol; 2015 Jul; 26(3):185-92. PubMed ID: 26197856
[TBL] [Abstract][Full Text] [Related]
18. Sustained complete remission of stage IVb carcinoma of the cervix with cis-platinum, methotrexate and bleomycin chemotherapy.
Burnet NG; Blake PR
Br J Radiol; 1989 Sep; 62(741):856-9. PubMed ID: 2477109
[No Abstract] [Full Text] [Related]
19. Platinum-free interval in second-line chemotherapy for recurrent cervical cancer.
Matoda M; Tanigawa T; Omatsu K; Ushioda N; Yamamoto A; Okamoto S; Kawamata Y; Kato K; Umayahara K; Takeshima N
Int J Gynecol Cancer; 2013 Nov; 23(9):1670-4. PubMed ID: 24172102
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR
Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
